Siemens Healthineers AG
SWB:SHL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Siemens Healthineers AG (SHL) under the Base Case is 48.29 EUR per share.
Compared with the current market price of 43.92 EUR, the stock appears
Undervalued by 9% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Siemens Healthineers Does
Siemens Healthineers AG makes medical equipment and software used in hospitals, clinics, and laboratories. Its core products include imaging systems such as MRI, CT, and X-ray machines, along with laboratory diagnostics tools and radiation therapy equipment. It also sells service contracts, software, and long-term maintenance that help customers install, run, and keep this equipment working.
- Headquarters
- Germany DE
- Employees
- 73 800
- IPO date
- Mar 16, 2018
Siemens Healthineers has no economic moat
Hospitals and laboratories can choose competing equipment, so Siemens Healthineers must keep winning business through product performance, service and price. Its technical expertise and established customer relationships help it compete, but do not provide dependable protection from rivals across its markets.
Read the full moat analysisRecent Events
Latest Earnings Call
Management set its fiscal 2027 outlook while outlining the Diagnostics carve-out, a sharper ultrasound focus and a new productivity program.
What management delivered: 2 within the range
Open the earnings call- EPS
- €0.69
- Expected
- €0.67
- Surprise
- +3.0%
- Stock, day of the call
- +0.3%
Past 12 months
Continue SHL Research
Decided on Siemens Healthineers? Get an email when SHL reaches the price you’d buy at. Free with an account.
Other Siemens Healthineers listings
What is the Intrinsic Value of one SHL stock?
The intrinsic value for
Siemens Healthineers AG (SHL) under the Base Case is 48.29 EUR.
Is SHL stock undervalued or overvalued?
Compared with the current market price of 43.92 EUR, the stock appears Undervalued by 9% .